Insight Pharma Affiliated Reports Adds New Reports to their Online Portfolio

PRLog (Press Release) - Jan. 7, 2013 - NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Reports Affiliated Reports Collection announces the addition of the following reports to the Affiliated Reports Collection:

Toll-Like Receptor (TLR) Agonists & Antagonists

Therapy Trends: Hepatitis C-KOL Insight Module

Antibody Partnering Terms and Agreements

Drug Delivery Partnering Terms and Agreements

Cancer Vaccine Partnering Agreements

Biomarkers in Drug Discovery

Bioinformatics Partnering Terms & Agreements

Biomarker Partnering Terms & Agreements

Companion Diagnostics Partnering Terms and Agreements

Personalized Medicine Partnering Terms and Agreements

Diagnostics Partnering Terms and Agreements

Diabetic Neuropathy - Pipeline Review

2012 CRO Quality Benchmarking

Metabolic Partnering Terms and

Immunology Partnering Terms and Agreements

Mucositis Partnering 2007-2012

Competitor Analysis: Tuberculosis Vaccines and Therapeutics

Therapy Trends: Multiple Sclerosis- KOL Insight and Consensus

Consensus Outlook: Multiple

Inflammatory Partnering 2007-2012

Systemic Lupus Partnering 2007-2012

AIDS Partnering 2007-2012

Central Nervous System Partnering Terms and Agreements

Biodefense Industry - Market to Benefit from Federal Funding

Read more about these report online at:  http://www.insightpharmareports.com/Reports/All.aspx

For more information and to purchase, visit: http://www.InsightPharmaReports.com or contact Kerri Simpson at ksimpson@healthtech.com or 781-972-1347.

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/